BCL-XL levels were higher in TI-Tregs than those within PB or TI CD8+ and Tconv cells in human BrCa (Fig. 1d and Supplementary Fig. 3a) and ccRCC (Fig. 1e, f and Supplementary Fig. 3b). The gene discussed is BCL2L1; the disease is invasive breast carcinoma.